All In Biotech

Drug Trial Radar · NCT07757204

An Open-label Long-term Safety Study of Buntanetap in Participants With AD

An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Alzheimer's Disease

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Nov 21, 2026

Primary completion

Feb 21, 2030

Study completion May 2030

Sponsor

Lead sponsor
Annovis Bio Inc.Industry
Sponsor type
Industry
First posted
Aug 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD.

Conditions

  • Alzheimer's Dementia (AD)

Interventions

  • buntanetap/posiphenDrug

    buntanetap 30 mg daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of buntanetapTime frame: 24 months of treatment
  2. Adverse Events (AE)Time frame: 24 months of study
  3. Treatment Emergent Adverse Events (TEAE)Time frame: 24 months of study
  4. Serious Adverse Events (SAE)Time frame: 24 months of study

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Cenexel Rocky Mountain Clinical Research

    Englewood, Colorado

  • K2 Medical Research Daytona

    Daytona Beach, Florida

  • K2 Medical Research

    Maitland, Florida

  • Merritt Island Medical Research, LLC

    Merritt Island, Florida

  • Conquest Research

    Orlando, Florida

  • Conquest Research, LLC

    Winter Park, Florida

  • Accel Neurosciences

    Decatur, Georgia

  • Center for Advanced Research & Education

    Gainesville, Georgia

  • Cenexel Advanced Medical Research of New Jersey (AMRI)

    Toms River, New Jersey

  • Advanced Clinical Institute

    West Long Branch, New Jersey

  • AMC Research/Flourish Research

    Matthews, North Carolina

  • Senior Adults Specialty Research

    Austin, Texas

  • Central Texas Neurology Associates

    Round Rock, Texas

  • Sana Research

    Arlington, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.